These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30258178)

  • 1. Neuroprotective efficacy of P7C3 compounds in primate hippocampus.
    Bauman MD; Schumann CM; Carlson EL; Taylor SL; Vázquez-Rosa E; Cintrón-Pérez CJ; Shin MK; Williams NS; Pieper AA
    Transl Psychiatry; 2018 Sep; 8(1):202. PubMed ID: 30258178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis.
    Walker AK; Rivera PD; Wang Q; Chuang JC; Tran S; Osborne-Lawrence S; Estill SJ; Starwalt R; Huntington P; Morlock L; Naidoo J; Williams NS; Ready JM; Eisch AJ; Pieper AA; Zigman JM
    Mol Psychiatry; 2015 Apr; 20(4):500-8. PubMed ID: 24751964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke.
    Loris ZB; Pieper AA; Dietrich WD
    Exp Neurol; 2017 Apr; 290():63-73. PubMed ID: 28077334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury.
    Blaya MO; Bramlett HM; Naidoo J; Pieper AA; Dietrich WD
    J Neurotrauma; 2014 Mar; 31(5):476-86. PubMed ID: 24070637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease.
    De Jesús-Cortés H; Xu P; Drawbridge J; Estill SJ; Huntington P; Tran S; Britt J; Tesla R; Morlock L; Naidoo J; Melito LM; Wang G; Williams NS; Ready JM; McKnight SL; Pieper AA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17010-5. PubMed ID: 23027934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Efficacy of an Aminopropyl Carbazole Derivative P7C3-A20 in Ischemic Stroke.
    Wang SN; Xu TY; Wang X; Guan YF; Zhang SL; Wang P; Miao CY
    CNS Neurosci Ther; 2016 Sep; 22(9):782-8. PubMed ID: 27333812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a proneurogenic, neuroprotective chemical.
    Pieper AA; Xie S; Capota E; Estill SJ; Zhong J; Long JM; Becker GL; Huntington P; Goldman SE; Shen CH; Capota M; Britt JK; Kotti T; Ure K; Brat DJ; Williams NS; MacMillan KS; Naidoo J; Melito L; Hsieh J; De Brabander J; Ready JM; McKnight SL
    Cell; 2010 Jul; 142(1):39-51. PubMed ID: 20603013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Effects of Delayed P7C3-A20 Treatment After Transient MCAO in Rats.
    Loris ZB; Hynton JR; Pieper AA; Dietrich WD
    Transl Stroke Res; 2018 Apr; 9(2):146-156. PubMed ID: 28842830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic P7C3 treatment restores hippocampal neurogenesis in the Ts65Dn mouse model of Down Syndrome [Corrected].
    Latchney SE; Jaramillo TC; Rivera PD; Eisch AJ; Powell CM
    Neurosci Lett; 2015 Mar; 591():86-92. PubMed ID: 25668489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-P7C3-S243 Protects a Rat Model of Alzheimer's Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia.
    Voorhees JR; Remy MT; Cintrón-Pérez CJ; El Rassi E; Khan MZ; Dutca LM; Yin TC; McDaniel LN; Williams NS; Brat DJ; Pieper AA
    Biol Psychiatry; 2018 Oct; 84(7):488-498. PubMed ID: 29246437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P7C3-A20 neuroprotection is independent of Wallerian degeneration in primary neuronal culture.
    Hill CS; Menon DK; Coleman MP
    Neuroreport; 2018 Dec; 29(18):1544-1549. PubMed ID: 30334859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
    Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
    Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Neuropsychiatric Disease-Associated Gene cacna1c Mediates Survival of Young Hippocampal Neurons.
    Lee AS; De Jesús-Cortés H; Kabir ZD; Knobbe W; Orr M; Burgdorf C; Huntington P; McDaniel L; Britt JK; Hoffmann F; Brat DJ; Rajadhyaksha AM; Pieper AA
    eNeuro; 2016; 3(2):. PubMed ID: 27066530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases.
    Pieper AA; McKnight SL; Ready JM
    Chem Soc Rev; 2014 Oct; 43(19):6716-26. PubMed ID: 24514864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice.
    Wang YH; Liou KT; Tsai KC; Liu HK; Yang LM; Chern CM; Shen YC
    Toxicol Appl Pharmacol; 2018 Oct; 357():88-105. PubMed ID: 30189238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis.
    Tesla R; Wolf HP; Xu P; Drawbridge J; Estill SJ; Huntington P; McDaniel L; Knobbe W; Burket A; Tran S; Starwalt R; Morlock L; Naidoo J; Williams NS; Ready JM; McKnight SL; Pieper AA
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):17016-21. PubMed ID: 23027932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea compound epigallo-catechin-3-gallate (EGCG) increases neuronal survival in adult hippocampal neurogenesis in vivo and in vitro.
    Ortiz-López L; Márquez-Valadez B; Gómez-Sánchez A; Silva-Lucero MD; Torres-Pérez M; Téllez-Ballesteros RI; Ichwan M; Meraz-Ríos MA; Kempermann G; Ramírez-Rodríguez GB
    Neuroscience; 2016 May; 322():208-20. PubMed ID: 26917271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition.
    Vázquez-Rosa E; Shin MK; Dhar M; Chaubey K; Cintrón-Pérez CJ; Tang X; Liao X; Miller E; Koh Y; Barker S; Franke K; Crosby DR; Schroeder R; Emery J; Yin TC; Fujioka H; Reynolds JD; Harper MM; Jain MK; Pieper AA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27667-27675. PubMed ID: 33087571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties.
    Naidoo J; De Jesus-Cortes H; Huntington P; Estill S; Morlock LK; Starwalt R; Mangano TJ; Williams NS; Pieper AA; Ready JM
    J Med Chem; 2014 May; 57(9):3746-54. PubMed ID: 24697290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of proneurogenic, neuroprotective small molecules.
    MacMillan KS; Naidoo J; Liang J; Melito L; Williams NS; Morlock L; Huntington PJ; Estill SJ; Longgood J; Becker GL; McKnight SL; Pieper AA; De Brabander JK; Ready JM
    J Am Chem Soc; 2011 Feb; 133(5):1428-37. PubMed ID: 21210688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.